ARCHIVES

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

NCI Advisory Group, Other Cancer Meetings

June 2, 1989

Electric Blankets May Be Risk Factor In Childhood Cancer

May 18, 1990

NCI CTEP Approved Trials For the Month of October

October 25, 2013

Small Study: Radiation, Chemo May Better Control Anal Cancer

November 26, 2010

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008